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In Brief
Inflammatory signaling in the CNS is
crucial in the development of obesity-
associated insulin and leptin resistance.
Tsaousidou et al. demonstrate that consti-
tutive JNK activation in agouti-related
peptide (AgRP)-expressing neurons is suf-
ficient to induce weight gain and leptin
resistance in mice, whereas IKK2 activa-
tion fails to cause obesity but blunts insu-
lin signaling and impairs systemic glucose
homeostasis. The data reveal distinct ef-
fects of c-Jun N-terminal kinase (JNK)-
and inhibitor of nuclear factor kappa-B ki-
nase (IKK)-dependent signaling in AgRP
neurons, which cooperate in the manifes-
tation of the metabolic syndrome.
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Activation of c-Jun N-terminal kinase 1 (JNK1)- and
inhibitor of nuclear factor kappa-B kinase 2 (IKK2)-
dependent signaling plays a crucial role in the devel-
opment of obesity-associated insulin and leptin
resistance not only in peripheral tissues but also in
the CNS. Here, we demonstrate that constitutive
JNK activation in agouti-related peptide (AgRP)-ex-
pressing neurons of the hypothalamus is sufficient
to induce weight gain and adiposity in mice as a
consequence of hyperphagia. JNK activation in-
creases spontaneous action potential firing of
AgRP cells and causes both neuronal and systemic
leptin resistance. Similarly, activation of IKK2 sig-
naling in AgRP neurons also increases firing of these
cells but fails to cause obesity and leptin resistance.
In contrast to JNK activation, IKK2 activation blunts
insulin signaling in AgRP neurons and impairs
systemic glucose homeostasis. Collectively, these
experiments reveal both overlapping and nonredun-
dant effects of JNK- and IKK-dependent signaling in
AgRP neurons, which cooperate in the manifestation
of the metabolic syndrome.
INTRODUCTION
Inflammatory processes play a crucial role during the develop-
ment of obesity and diabetes mellitus (Hotamisligil, 2008). In
adipose tissue, obesity leads to the recruitment of immune
cells, which release cytokines such as tumor necrosis factor
and interleukin-6 (Hotamisligil, 2008). These and other cyto-
kines are able to activate inflammatory signaling cascadesCell Resuch as c-Jun N-terminal kinase 1 (JNK1) and inhibitor of nu-
clear factor kappa-B kinase 2 (IKK2) (Li and Verma, 2002; Bo-
goyevitch, 2006) in insulin target tissues, thereby promoting the
development of insulin resistance. The critical role of these ki-
nases in obesity-induced insulin resistance has been defined
through the generation of haploinsufficient conditional IKK2
knockout mice as well as hepatocyte- and myeloid-cell-specific
IKK2-deficient mice, which are protected against systemic in-
sulin resistance and glucose intolerance (Yuan et al., 2001; Ar-
kan et al., 2005; Cai et al., 2005). Similarly, conventional JNK1,
but not JNK2, knockout mice are protected against obesity and
glucose intolerance (Hirosumi et al., 2002). In addition to
obesity-associated activation of cytokine signaling, obesity
can overload the cellular protein-folding capacity, leading to
activation of the ER stress response, which in turn activates
JNK1 and IKK2 (Ozcan et al., 2004, 2006). Moreover, nutrient
components such as saturated fatty acids can activate both
JNK1 and IKK2 signaling through the engagement of Toll-like
receptor (TLR)-dependent signaling or as a consequence of
excessive ceramide synthesis (Shi et al., 2006; Holland et al.,
2007). Taken together, activation of these two kinases repre-
sents a hallmark in the development of insulin resistance in pe-
ripheral tissues.
In the CNS, the onset of hypothalamic leptin and insulin
resistance is a key event in the development of obesity and
impaired glucose homeostasis (Vogt and Bru¨ning, 2013;
Plum et al., 2006a; Belgardt and Bru¨ning, 2010). Both the ad-
ipose-tissue-derived hormone leptin and the pancreatic hor-
mone insulin act on hypothalamic neurons to decrease food
intake and hepatic glucose production and, further, to increase
energy expenditure (Obici et al., 2002a, b; Belgardt and Bru¨n-
ing, 2010; Ring and Zeltser, 2010). Several hypothalamic neu-
rons are directly regulated by these hormones, with the role of
pro-opiomelanocortin (POMC) and the agouti-related peptide
(AgRP) neurons being best defined. Acute ablation of POMCports 9, 1495–1506, November 20, 2014 ª2014 The Authors 1495
neurons induces hyperphagia, whereas ablation of AgRP neu-
rons leads to anorexia (Gropp et al., 2005; Luquet et al., 2005).
Similarly, optogenetic activation of POMC neurons reduces
food intake and body weight, whereas activation of AgRP
evokes voracious feeding (Aponte et al., 2011). Accordingly,
leptin and insulin receptor signaling in POMC or AgRP neurons
is necessary for normal regulation of body weight and glucose
homeostasis (Balthasar et al., 2004; Kitamura et al., 2006; van
de Wall et al., 2008; Belgardt et al., 2008; Xu et al., 2007).
Importantly, lack of insulin signaling in AgRP neurons is suffi-
cient to deregulate hepatic glucose production (Ko¨nner et al.,
2007; Lin et al., 2010), whereas combined leptin and insulin re-
ceptor deficiency in POMC neurons induces systemic insulin
resistance (Hill et al., 2010). Of note, both POMC and AgRP
neurons are intimately involved in the normal regulation of en-
ergy homeostasis not only in rodents but also in humans (Coll
et al., 2007).
Whereas these and other investigations have defined neuronal
populations directly targeted by insulin and leptin for the regula-
tion of energy homeostasis and glucose metabolism, multiple
studies have revealed the development of insulin and leptin
resistance in the CNS of obese animals and human patients
(Mu¨nzberg et al., 2004; Enriori et al., 2007; Hallschmid et al.,
2008; Belgardt and Bru¨ning, 2010).
Both ER stress and increased proinflammatory cytokine
expression have been detected in the hypothalami of obese
mice and rats (De Souza et al., 2005; Ozcan et al., 2009). Like-
wise, neuronal ablation of the TLR adaptor molecule MyD88 is
sufficient to maintain hypothalamic leptin sensitivity despite
acute palmitate treatment or in chronically obese mice (Klein-
ridders et al., 2009), and hypothalamic IKK2 and JNK1 activa-
tion has been reported in obese mice and rats (De Souza
et al., 2005; Zhang et al., 2008; Belgardt et al., 2010).
Conversely, mice with CNS-wide ablation of IKK2 were pro-
tected from high-fat diet (HFD)-induced obesity and glucose
intolerance (Zhang et al., 2008), and we and others could
demonstrate that JNK1 ablation in the CNS is sufficient to
improve hypothalamic and systemic insulin sensitivity upon
HFD consumption (Belgardt et al., 2010; Sabio et al., 2010; Un-
ger et al., 2010).
However, whereas both neuronal JNK1 and IKK2 inhibition
protects from HFD-associated pathologies, it has not yet
been demonstrated in which hypothalamic neuronal population
JNK1 and/or IKK2 action deregulates energy and/or glucose
homeostasis and whether neuron-restricted JNK1 and/or
IKK2 activation are sufficient to alter energy and glucose ho-
meostasis. In the present study, we demonstrate that activation
of JNK signaling specifically in AgRP neurons results in
increased body weight and adiposity by progressively impairing
neuronal leptin signaling and systemic leptin sensitivity. On the
other hand, IKK2 activation promotes insulin resistance in
AgRP neurons and ultimately also in the periphery without
affecting energy homeostasis. Thus, we reveal that activation
of both IKK and JNK signaling in AgRP neurons is sufficient
to promote the development of hallmarks of the metabolic syn-
drome, but we also identify distinct and nonoverlapping roles
for both inflammatory signaling mediators in AgRP neurons in
this process.1496 Cell Reports 9, 1495–1506, November 20, 2014 ª2014 The AutRESULTS
Activation of JNK Signaling in AgRP Neurons Occurs in
Obesity and Increases Firing of These Cells
To assess whether JNK activation occurs in AgRP neurons during
obesity development, we employed a reporter mouse strain that
allows for genetic identification of AgRP/neuropeptide Y (NPY)-
coexpressing neurons via expression of humanized Renilla GFP
under the control of the mouse Npy promoter (NPYGFP) and fed
8-week-old mice with normal chow diet (NCD) (NCD:NPYGFP) or
HFD for 10 days (HFD:NPYGFP). Immunostaining for phosphory-
lated c-Jun—as a readout for JNK activation and a crucial regu-
lator ofhypothalamic inflammation (DeSouzaetal., 2005;Belgardt
et al., 2010; Sabio et al., 2010; Unger et al., 2010)—in combination
with GFP revealed an 3-fold increase of p-c-Jun immunoreac-
tivity inGFP-positiveneurons inNPYGFPmiceafterHFDconsump-
tion compared to the NCD-fed NPYGFP mice (Figures 1A and 1B).
These data indicate that, indeed early during the course of HFD
feeding, JNK is activated in AgRP neurons.
To address whether JNK activation per se in AgRP neurons, as
observed upon obesity development and HFD consumption (Fig-
ures1Aand1B), is sufficient to inducemetabolic abnormalities,we
sought to generate a genetic mouse model for cell-type-specific
JNK activation. Constitutive activation of JNK has previously
been achieved by expression of a constitutively active version
of the upstream kinase JNKK2/MKK7 (MKK7D; Wang et al.,
1998) or a fusion protein consisting of JNKK2/MKK7 and JNK1
(JNKK2-JNK1;Zhengetal., 1999).Thus,wegeneratedmiceallow-
ing for the conditional expressionof aMKK7D-JNK1 fusionprotein
uponCre-recombinase-induced excision of a transcriptional Stop
cassette (R26StopFLJNK1CA mice) from the ROSA26 locus (Pal
et al., 2013). In order to activate JNK signaling in AgRP neurons,
we crossed R26StopFLJNK1CA mice with mice expressing the
Cre-recombinase in these cells (AgRPCre+/; Tong et al., 2008).
To investigate the efficiency of this transgenic approach to
activate JNK, we generated reporter mice expressing GFP in
AgRP neurons by crossing the AgRPCre with the Z/EG mice, in
the presence or absence of JNK1CA expression. Immunostain-
ing for phosphorylated c-Jun —as a read-out for JNK activa-
tion—in combination with GFP revealed that less than 20% of
GFP+-AgRP neurons exhibited p-c-Jun immunoreactivity in
lean control animals, whereas in AgRPJNK1CA;GFP mice, more
than 70% of GFP+-AgRP neurons showed detectable phosphor-
ylation of c-Jun (Figures 1C and 1D), in fact, to similar degree as
observed upon HFD feeding. Importantly, constitutive JNK acti-
vation in AgRP neurons did not affect the total number of
GFP+-AgRP cells, although JNK1 had been implicated in a cell-
type-specific regulation of cell death and survival (Bogoyevitch,
2006; Figure 1E). Taken together, these results indicate that the
AgRPJNK1CA mice are a suitable model to investigate the physio-
logical consequences of chronically activated JNK1 signaling in
AgRP neurons without altering AgRP neuron viability.
To determine the effect of activated JNK signaling on the
cellular properties of AgRP neurons, we first investigated the
electrophysiological parameters of AgRP neurons. Here, we
employed the NPYGFP reporter mouse strain and crossed it to
AgRPJNK1CA and the respective control mice. Perforated
patch-clamp recordings of genetically identified AgRP/NPYhors
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Figure 1. Activation of JNK Signaling in
AgRP Neurons Occurs in Obesity and In-
creases Firing of These Cells
(A and B) High-fat diet consumption for 10 days is
sufficient to trigger c-Jun phosphorylation in AgRP
neurons of NPYGFP reporter mice. Immunostaining
for phospho-c-Jun and GFP performed in arcuate
nuclei of NPYGFP reporter mice at the age of
10 weeks fed with normal chow diets (NCD) or
high-fat diet for 10 days (HFD). The number of p-c-
Jun and GFP double-positive neurons was signifi-
cantly increased in NPYGFP mice fed with HFD
(HFD:NPYGFP; n = 3) compared to NPYGFPmice fed
with normal chow diet (NCD:NPYGFP; n = 3). The
scale bar represents 40 mm.
(C andD) Expressionof the JNK1CAprotein inAgRP
neurons leads to cell-specific phosphorylation of
the JNK target c-Jun in vivo. AgRP neurons were
visualized by immunostaining for GFP in AgRPGFP
and AgRPJNK1CA;GFP reporter animals. Immuno-
staining for phospho-c-Jun revealed few AgRP
neurons positive for p-c-Jun in control reporter an-
imals, whereas the majority of AgRP neurons in
AgRPJNK1CA;GFP mice showed clear immunoreac-
tivity for p-c-Jun. Quantification of p-c-Jun and
GFP-positive AgRP neurons is depicted in (D) in
control AgRPGFP (n = 3) and AgRPJNK1CA;GFP (n = 3)
reporter mice. The scale bar represents 100 mm.
(E) Chronic JNK1 activation does not affect AgRP
neuron numbers. All GFP+ AgRP neurons were
counted in control AgRPGFP (n = 3) and
AgRPJNK1CA;GFP (n = 3) reporter mice. No differ-
ence in neuron counts per slide was detected be-
tween genotypes.
(F) Spontaneous action potential frequencies of
NPYGFP;JNK1CA;AgRPCre/ (n = 3 mice; n = 13
AgRP neurons) and NPYGFP;AgRPJNK1CA (n = 3
mice; n = 9 AgRP neurons). AP, action potential.
(G) Membrane potentials of NPYGFP;JNK1CA;
AgRPCre/ (n = 3 mice; n = 13 AgRP neurons) and
NPYGFP/AgRPJNK1CA (n = 3 mice; n = 8 AgRP
neurons).
(H) Representative recordings of spontaneous
action potential frequencies of NPYGFP;JNK1CA;
AgRPCre/ and NPYGFP/AgRPJNK1CA mice at the
age of 6 weeks.
Displayed values aremeans ±SEM. *p < 0.05; **p <
0.01; ***p < 0.001. See also Figure S1.neurons revealed that activation of JNK signaling in AgRP neu-
rons of NPYGFP;AgRPJNK1CA mice increased the spontaneous
firing frequency of these cells and depolarized the membrane
potential compared to AgRP/NPY neurons of lean control litter-
mates (NPYGFP;JNK1CA;AgRPCre/; Figures 1F–1H). We did
not observe any differences in other basic electrophysiological
properties, such as input resistance, cell capacitance, and
spike-frequency adaptation (Figure S1).
JNK Activation in AgRP Neurons Causes Cellular and
Systemic Leptin Resistance
Apart from regulating neuronal firing of AgRP neurons, leptin ex-
erts its regulatory role on feeding behavior through Stat3-depen-
dent regulation of neuropeptide expression, including that ofCell ReAgRP and NPY (Bates and Myers, 2003). Thus, we directly as-
sessed leptin’s ability to activate STAT3 phosphorylation in
AgRP neurons of AgRPJNK1CA and control mice. To this end,
we employed mice, which allow for Cre-dependent expression
of b-galactosidase (Plum et al., 2006b), and crossed these ani-
mals with AgRPJNK1CA mice, yielding both control mice with
genetically marked AgRP neurons (AgRPLacZ mice) as well as
AgRPJNK1CA;LacZ mice. Whereas in vivo leptin stimulation mark-
edly induced Stat3 phosphorylation in AgRP neurons of
10-week-old control mice, leptin’s ability to induce pSTAT3
immunoreactivity in AgRP neurons of AgRPJNK1CA;LacZ mice
was largely reduced, demonstrated both as the percentage of
pSTAT3 immunoreactive LacZ-positive cells per section (Figures
2A and 2B) and as intensity of the pSTAT3 immunoreactivity inports 9, 1495–1506, November 20, 2014 ª2014 The Authors 1497
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Figure 2. JNK1 Activation Causes AgRP-
Neuron-Specific and Subsequently Systemic
Leptin Resistance
(A) Representative pSTAT3 immunostaining of
AgRPLacZ and AgRPJNK1CA;LacZ after fasting for
16 hr and intraperitoneal leptin stimulation (1 mg/kg)
in 10-week-old animals. The scale bar represents
40 mm.
(B) Average number of pSTAT3 and LacZ immuno-
reactive cells per section of control AgRPLacZ (n = 3)
and AgRPJNK1CA;LacZ (n = 3) mice.
(C) Average number pSTAT3 immunoreactive non-
AgRP (LacZ-negative) cells after leptin stimulation is
indistinguishable between AgRPLacZ (n = 3) and
AgRPJNK1CA;LacZ (n = 3) mice. The same images as
for (B) were used for quantification.
(D) Changes in body weight after intraperitoneal
leptin treatment in control (n = 7) and AgRPJNK1CA
(n = 7) mice at 8 weeks of age. Data represent
percentage of basal bodyweight (the bodyweight in
the beginning of each treatment) after a 3-day (72 hr)
treatment with twice-daily injections (12 hr apart) of
saline followed by a 3-day treatment with twice-
daily injections of 2 mg/kg leptin.
(E) Changes in food intake after intraperitoneal
leptin treatment in control (n = 7) and AgRPJNK1CA
(n = 7) mice at 8 weeks of age. Data represent daily
food intake after a 3-day (72 hr) treatment with
twice-daily injections (12 hr apart) of saline followed
by a 3-day treatment with twice-daily injections of
2 mg/kg leptin.
(F) As in (D), but at 15weeks of age of control (n = 10)
and AgRPJNK1CA (n = 4) mice.
(G) As in (E), but at 15 weeks of age of control
(n = 10) and AgRPJNK1CA (n = 4) mice.
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01; ***p < 0.001. See also Figure S2.LacZ-positive cells (Figure S2A; for detailed information please
see Supplemental Experimental Procedures). Thus, activating
JNK signaling in AgRP neurons induces leptin resistance in these
cells. This effect is AgRP-cell-specific, because pSTAT3 immu-
noreactivity after leptin stimulation is not affected in non-AgRP
cells (Figures 2C and S2B).
To investigate systemic leptin sensitivity, control and
AgRPJNK1CA mice were injected twice daily for 3 consecutive
days with saline followed by twice-daily injections for 3 consec-
utive days with 2 mg/kg leptin. Leptin treatment significantly
reduced food intake and body weight in both control and
AgRPJNK1CA mice at 8 weeks of age (Figures 2D and 2E). Impor-
tantly, at the age of 15 weeks, leptin treatment failed to suppress
food intake and to reduce body weight in AgRPJNK1CA mice,
whereas control mice still responded to the food-intake- and
body-weight-reducing action of leptin (Figures 2F and 2G). Of
note, leptin resistance at this age occurred in weight-matched
animals to rule out a potential confounding effect of increased1498 Cell Reports 9, 1495–1506, November 20, 2014 ª2014 The Authorsbody weight between the two genotypes
(Figures S2D and S2E). Collectively, these
experiments reveal that chronic activation
of JNK signaling in AgRP neurons is suffi-cient to initially cause cell-autonomous and subsequently sys-
temic leptin resistance.
Activation of JNK Signaling in AgRP Neurons Causes
Obesity
To address the effect of activating JNK signaling in AgRPneurons
on energy homeostasis, we monitored the body weight of male
control and AgRPJNK1CA mice. Whereas body weight did not
differ between genotypes at the beginning of our analysis,
AgRPJNK1CAmice displayed progressively increased bodyweight
starting at the age of 5 weeks, which continued until the end of
our study at 28 weeks of age (Figure 3A). Moreover, analysis of
body composition revealed increased adipose tissue mass in
AgRPJNK1CA compared to control mice (Figure 3B), which was
associated with adipocyte hyperplasia (Figures 3C and 3D).
In light of the increased body weight and adiposity of
AgRPJNK1CA mice, we aimed to identify the mechanism of how
AgRP-neuron-specific activation of JNK signaling caused a
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Figure 3. Chronic JNK1 Signaling in AgRP
Neurons Results in Increased Body Weight
and Adiposity
(A) Average body weight of control (n = 20) and
AgRPJNK1CA mice (n = 20) on normal diet.
(B) Average body fat as measured by nuclear
magnetic resonance analysis of control (n = 12)
and AgRPJNK1CA mice (n = 14) on normal diet at
the age of 25 weeks.
(C) Representative pictures of epididymal adipose
tissue paraffin sections. The scale bar represents
50 mm. Average fat cell area of control (n = 3) and
AgRPJNK1CA mice (n = 4) at the age of 25 weeks.
(D) Fat cell area distribution of control (n = 3) and
AgRPJNK1CA mice (n = 4) at the age of 25 weeks.
(E) Average ad libitum food intake at the age of
6 weeks of control (n = 12) and AgRPJNK1CA mice
(n = 12).
(F) Locomotor activity at the age of 6 weeks of
control (n = 7) and AgRPJNK1CA mice (n = 7).
(G) Energy expenditure at the age of 6 weeks of
control (n = 7) and AgRPJNK1CA mice (n = 7).
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01.positive energy balance. These analyses revealed that daily food
intake was significantly increased upon activation of JNK sig-
naling in AgRP cells (Figure 3E), whereas locomotor activity
and energy expenditure remained unaltered in AgRPJNK1CA
mice compared to control mice (Figures 3F and 3G). Thus, acti-
vation of JNK signaling in AgRP neurons is sufficient to promote
hyperphagia and obesity development in mice.
Unaltered Glucose Homeostasis in AgRPJNK1CA Mice
Insulin action in AgRP neurons is critical for the control of hepatic
glucose output (Ko¨nner et al., 2007; Lin et al., 2010). Insulin acti-
vates the phosphatidylinositol 3-kinase (PI3K) cascade in AgRPCell Reports 9, 1495–1506, Noneurons, which catalyzes the generation
of phosphatidylinositol 3,4,5 triphosphate
(PIP3) from phosphatidylinositol 4,5 di-
phosphate (PIP2). To examine whether
JNK activation leads to the development
of insulin resistance,we investigated theef-
fect of constitutive JNK activation in AgRP
neurons on insulin’s ability to activate
PI3K signaling in these cells by immuno-
staining for PIP3 in genetically marked
b-galactosidase-positive AgRP neurons of
mice expressing LacZ in AgRP neurons in
the presence or absence of JNK1CA ex-
pression (AgRPJNK1CA;LacZ and AgRPLacZ,
respectively). In bothAgRPJNK1CA and con-
trolmice, insulin treatment resulted in com-
parable PIP3 formation in AgRP neurons,
indicating that activation of JNK signaling
did not cause neuronal insulin resistance
in this cell type (Figures 4A and 4B). Basal
levels of immunoreactive PIP3 were also
indistinguishable between AgRPLacZ andAgRPJNK1CA;LacZ mice (Figure 4C). Consistent with unaltered insu-
lin action in AgRP neurons, systemic glucose homeostasis re-
mained unaffected in AgRPJNK1CA compared to control mice as
assessed by insulin and glucose tolerance tests (Figures 4D and
4Eand thebodyweights inFigureS3). Thus, these experiments re-
vealed the development of leptin, but not insulin resistance, as a
consequence of JNK activation in AgRP neurons.
Activation of IKK2 Signaling Increases the Firing Rate of
AgRP Neurons
Because activation of JNK signaling in AgRP neurons was suffi-
cient to induce obesity and leptin resistance, but neither causedvember 20, 2014 ª2014 The Authors 1499
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Figure 4. Unaltered AgRP-Neuronal Insulin
Sensitivity and Glucose Homeostasis in
AgRPJNK1CA Mice
(A) Representative PIP3 immunostaining of
AgRPLacZ and AgRPJNK1CA;LacZ after intravenous
insulin stimulation with 5 U of insulin. The scale bar
represents 10 mm.
(B) Quantification of PIP3 levels in AgRP neurons of
AgRPLacZ (n = 5 mice; n = 460 AgRP neurons) and
AgRPJNK1CA;LacZ (n = 3 mice; n = 148 AgRP neu-
rons) mice after fasting for 16 hr and insulin stim-
ulation (in the vena cava inferior) with 5 U of insulin
for 10 min.
(C) Quantification of PIP3 levels in AgRP neurons of
AgRPLacZ (n = 3 mice; n = 234 AgRP neurons) and
AgRPJNK1CA;LacZ (n = 3 mice; n = 346 AgRP neu-
rons) mice in basal state (saline injection in the vena
cava inferior) after fasting for 16 hr.
(D) Blood glucose levels as percentage of the initial
blood glucose during an insulin tolerance test of
control (n = 14) and AgRPJNK1CA mice (n = 18).
(E) Blood glucose levels during glucose tolerance
test of control (n = 9) and AgRPJNK1CA (n = 11) mice.
The mice were fasted for 6 hr before the injection
with 20% glucose (10 ml/kg).
Displayed values are means. See also Figure S3.neuronal insulin resistance nor impaired systemic glucose meta-
bolism, we sought to investigate whether chronic activation of
IKK2 signaling in AgRP neurons would impact on the regulation
of energy homeostasis and/or glucose homeostasis. Therefore,
we generated mice expressing a constitutive active IKK2 mutant
(IKK2CA) (Sasaki et al., 2006) specifically in AgRP neurons
(AgRPCreR26StopFL/WTIKK2EE, referred to as AgRPIKK2CA
mice). Given that, in this mouse model, IKK2EE expression is
driven by the endogenous ROSA-26 promoter, which exhibits
lower expression than the construct employed for expressing
the JNK1CA variant, we generated homozygous mice express-
ing two copies of IKK2CA (AgRPIKK2CA/CA) to achieve a more-
robust expression of the IKK2CA variant.
To test the functionality of this approach, we employed pIkBa
immunostaining as a readout for IKK2 activation in AgRP neu-
rons of reporter mice expressing b-galactosidase in AgRP neu-
rons upon Cre-mediated expression of LacZ from the ROSA26
locus. Because both the b-galactosidase reporter as well as
the IKK2CA allele were expressed from the ROSA allele, we
compared the degree of pIkBa immunoreactivity in control
AgRPLacZ mice and AgRPIKK2CA;LacZ mice, which express only
one copy of the IKK2CA allele. Whereas approximately 45% of1500 Cell Reports 9, 1495–1506, November 20, 2014 ª2014 The Authorsb-galactosidase-positive neurons dis-
played pIkBa immunoreactivity in control
AgRPLacZ mice, AgRP-specific constitu-
tive activation of IKK2 resulted in pIkBa
immunoreactivity in approximately 70%
of b-galactosidase-positive neurons in
AgRPIKK2CA;LacZ mice (Figures 5A and
5B). Constitutive IKK2 activation in AgRP
neurons did not affect the total numberof LacZ+-AgRP cells (Figure 5C). Collectively, these experiments
reveal successful activation of IKK2 signaling in AgRP neurons in
mice, already in those that express only one copy of the IKK2CA
allele.
Next, we performed electrophysiological recordings of genet-
ically marked NPYGFP neurons of control NPYGFP;IKK2CA/CA;
AgRPCre/ or NPYGFP;AgRPIKK2CA/CA mice. Similar to what we
had observed in NPYGFP;AgRPJNK1CA mice, activation of IKK2
signaling in AgRP neurons increased their firing rate compared
to AgRP neurons of control mice (Figures 4D–4F). Again, other
basic electrophysiological properties remained unaltered (Fig-
ure S1). These experiments indicate that activation of both major
inflammatory mediators JNK1 and IKK2 propagate increased
activity of orexigenic AgRP/NPY neurons in the arcuate nucleus
in a cell-autonomous manner.
Activation of IKK2 Signaling in AgRP Neurons Does Not
Affect Leptin Sensitivity or Body Weight
In contrast towhatwe observed in AgRPJNK1CAmice, leptin-medi-
ated suppression of food intake was retained in AgRPIKK2CA/CA
mice to the same degree as in control animals even at the age
of 15 weeks, when AgRPJNK1CA mice develop profound systemic
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Figure 5. Activation of IKK2 Signaling In-
creases the Firing Rate of AgRP Neurons
(A and B) Expression of the IKK2CA protein in
AgRP neurons leads to cell-specific phosphoryla-
tion of the IKK2 target IkBa in vivo. AgRP neurons
were visualized by immunostaining for b-galacto-
sidase in AgRPLacZ and AgRPIKK2CA;LacZ reporter
animals. Immunostaining for phospho-IkBa re-
vealed 45%of the AgRP neurons positive in control
reporter animals, whereas 70%of AgRP neurons in
AgRPIKK2CA;LacZ mice showed clear immunoreac-
tivity for p-IkBa. Quantification of p-IkBa-positive
and b-galactosidase-positive AgRP neurons is
depicted in (B) in control AgRPLacZ (n = 3) and
AgRPIKK2CA;LacZ (n = 3) reporter mice. The scale bar
represents 50 mm.
(C) Chronic IKK2 activation does not affect AgRP
neuron numbers. b-galactosidase-positive AgRP
neurons were counted in control AgRPLacZ (n = 3)
and AgRPIKK2CA;LacZ (n = 3) reporter mice. No dif-
ference in neuron counts per slide was detected
between genotypes.
(D) Spontaneous action potential frequencies of
NPYGFP;IKK2CA/CA;AgRPCre/ (n = 3 mice; n =
17 AgRP neurons) and NPYGFP;AgRPIKK2CA/CA (n =
3 mice; n = 11 AgRP neurons).
(E) Membrane potentials of NPYGFP;IKK2CA/CA;
AgRPCre/ (n = 3 mice; n = 17 AgRP neurons) and
NPYGFP;AgRPIKK2CA/CA (n = 3 mice; n = 11 AgRP
neurons).
(F) Representative recordings of spontaneous ac-
tion potential frequencies of NPYGFP;IKK2CA/CA;
AgRPCre/ and NPYGFP;AgRPIKK2CA/CA mice at
the age of 6 weeks. Displayed values are means ±
SEM. *p < 0.05.leptin resistance (Figures 6A and 6B). Taken together, activating
IKK2 signaling in AgRP neurons does not interfere with body
weight maintenance or leptin sensitivity, in contrast to what is
observed upon activation of JNK signaling in the same neurons.
Upon validation of the functionality of the constitutively active
IKK2 variant expressed in AgRP neurons, we performed a meta-
bolic characterization of AgRPIKK2CA/CA and their respective con-
trol mice. In contrast to what we had observed in AgRPJNK1CA
mice, AgRPIKK2CA/CA mice did not develop increased body
weight or adiposity (Figures 6C and 6D) despite a slightly
elevated food intake compared to controls (Figure 6E). Similarly,
locomotor activity and energy expenditure remained unaltered
between genotypes (Figures 6F and 6G).
Impaired Glucose Homeostasis in AgRPIKK2CA/CA Mice
Despite unaltered body weight and adiposity, AgRPIKK2CA/CA
mice displayed impaired insulin sensitivity andmild glucose intol-
erance as compared to control mice (Figures 7A and 7B).
Because glucose homeostasis critically depends on the abilityCell Reports 9, 1495–1506, Noof insulin to activate PI3K in AgRP neu-
rons, leading to subsequent membrane
hyperpolarization of these neurons, we
investigated the ability of insulin to activate
PI3K signaling in AgRP neurons of control
AgRPLacZ mice and AgRPIKK2CA;LacZ mice.Whereas intravenous insulin stimulation induced high levels of
immunoreactive PIP3 in approximately 60% of AgRP neurons
in control mice, this proportion was significantly reduced to
40% in mice expressing only one IKK2CA allele (Figures 7C
and 7D). Of note, at basal levels, the amount of PIP3 formation
was also indistinguishable between AgRPIKK2CA;LacZ and control
mice (Figure 7E). Thus, activating IKK2 signaling in AgRP neurons
causes cell-autonomous insulin resistance and subsequently im-
pairs systemic insulin sensitivity in the absence of altered body
weight regulation.
DISCUSSION
Hypothalamic inflammation is recognized as a critical feature of
diet-induced neuronal leptin and insulin resistance (Zhang et al.,
2008; Belgardt et al., 2010; Thaler et al., 2012). Whereas hypo-
thalamic activation of inflammatory pathways including that of
JNK- and IKK2-mediated signaling had been reported early
upon high-fat feeding of mice (De Souza et al., 2005), thevember 20, 2014 ª2014 The Authors 1501
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Figure 6. Chronic Activation of IKK2
Signaling in AgRP Neurons Does Not Affect
Body Weight and Leptin Sensitivity
(A) Changes in body weight after intraperitoneal
leptin treatment in control (n = 7) and AgRPJNK1CA
(n = 7) mice at 15 weeks of age. Data represent
percentage of basal body weight (body weight
in the beginning of each treatment) after a 3-day
(72 hr) treatment with twice-daily injections (12 hr
apart) of saline followed by a 3-day treatment with
twice-daily injections of 2 mg/kg leptin.
(B) Changes in food intake after intraperitoneal
leptin treatment in control (n = 5) and AgRPJNK1CA
(n = 5) mice at 15 weeks of age. Data represent
daily food intake after a 3-day (72 hr) treatment
with twice-daily injections (12 hr apart) of saline
followed by a 3-day treatment with twice-daily
injections of 2 mg/kg leptin.
(C) Average body weight of control (n = 20) and
AgRPIKK2CA/CA mice (n = 20) on normal chow diet.
(D) Body fat as measured by nuclear magnetic
resonance analysis of control mice (n = 8) and
AgRPIKK2CA/CA mice (n = 7) on normal chow diet at
the age of 20 weeks.
(E) Average ad libitum food intake of control (n = 10)
and AgRPIKK2CA/CA mice (n = 7) at the age of 6
weeks.
(F) Locomotor activity of control (n = 20) and
AgRPIKK2CA/CA mice (n = 19).
(G) Energy expenditure at the age of 6 weeks of
control (n = 20) and AgRPIKK2CA/CA mice (n = 19) at
the age of 6 weeks.
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01.functional significance of this phenomenon remained unclear,
because it was conceivable that hypothalamic inflammation
could contribute to the development of CNS insulin and/or leptin
resistance or maybe even represent a homeostatic, compensa-
tory mechanism to counteract the consequences of obesity.
Nevertheless, recent experiments demonstrating that attenua-
tion of neuronal IKK2, JNK1, TLR, and ER stress signaling pro-
tect from the development of diet-induced obesity (Zhang
et al., 2008; Kleinridders et al., 2009; Belgardt et al., 2010) indi-
cate that hypothalamic inflammation at least chronically contrib-
utes to the manifestation of the metabolic syndrome.
However, the contribution of different cell types that reside in
the hypothalamus, such as astrocytes, microglia, stem cells,
endothelial cells, and neurons, to the initiation and manifestation
of hypothalamic inflammation is only partially understood (Gar-
cı´a-Ca´ceres et al., 2013; Gao et al., 2014; Purkayastha and
Cai, 2013; Gosselin and Rivest, 2008). Moreover, due to the di-
versity and partial functional antagonism of distinct hypothalam-
ic neurons, we sought to first clarify the role of inflammatory
signaling in AgRP neurons of the arcuate nucleus in the manifes-
tation of the metabolic syndrome. To this end, the present study
clearly reveals that activation of JNK and IKK2 in these cells is
sufficient to initiate key features of the metabolic syndrome,
even in the absence of additional environmental triggers, such
as high-fat feeding. At the same time, our results demonstrate
that activation of inflammatory signaling pathways in neurons
is a crucial determinant in the pathogenesis of obesity and1502 Cell Reports 9, 1495–1506, November 20, 2014 ª2014 The Autimpaired insulin sensitivity, even in the absence of altered micro-
glia function.
Interestingly, our experiments reveal common and distinct
consequences of AgRP-neuron-restricted JNK versus IKK2
activation. Activation of either inflammatory signaling branch
results in increased firing of AgRP neurons. In fact, both JNK
and IKK2 have been demonstrated to regulate glutamatergic
signaling and synapse maturation, raising the possibility that
both inflammatory kinases promote AgRP neuron excitability
via similar or distinct pathways (Thomas et al., 2008; Bockhart
et al., 2009; Ahn and Choe, 2010; Schmeisser et al., 2012).
Interestingly, despite the fact that, in both models, AgRP firing
is increased by 2-fold (Figure S1I), only the AgRPJNK1CA mice
develop obesity. As optogenetic stimulation has clearly defined
that robustly increasing AgRP neuron firing evokes voracious
feeding, our experiments reveal that slight increases in AgRP
firing per se do not cause obesity. Despite increased firing at
young age, as detected in our animals, compensatory mecha-
nisms might normalize electrical activity of these cells in long
term despite increased JNK and IKK2 activity. Ultimately,
we cannot rule out that yet unidentified cellular hetero-
geneity of AgRP neurons—as observed for POMC neurons—
may contribute to these differential outcomes (Williams et al.,
2010).
Despite the similar alterations of neuronal firing upon JNK and
IKK2 activation, only activating JNK in AgRP neurons promotes
initially cellular and subsequently systemic leptin resistance.hors
AC
D E
B Figure 7. Impaired Glucose Homeostasis in
AgRPIKK2CA/CA Mice
(A) Blood glucose levels as percentage of the initial
blood glucose during an insulin tolerance test of
control (n = 21) and AgRPIKK2CA/CA (n = 20).
(B) Blood glucose levels during glucose tolerance
test of control (n = 8) and AgRPIKK2CA/CA (n = 7). The
mice were fasted for 6 hr before the experiment.
(C) Representative PIP3 immunostaining of
AgRPLacZ (same as depicted in Figure 4A) and
AgRPIKK2CA;LacZ mice after intravenous insulin
stimulation with 5 U of insulin. The scale bar rep-
resents 10 mm.
(D) Quantification of PIP3 levels in AgRP neurons of
AgRPLacZ (n = 5mice; n = 460 AgRP neurons; same
as depicted in Figure 4B) and AgRPIKK2CA;LacZ (n =
5 mice; n = 357 AgRP neurons) mice after fasting
for 16 hr and insulin stimulation (in the vena cava
inferior) with 5 U of insulin for 10 min.
(E) Quantification of PIP3 levels in AgRP neurons of
AgRPLacZ (n = 3mice; n = 234 AgRP neurons; same
as depicted in Figure 4C) and AgRPIKK2CA;LacZ (n =
3 mice; n = 256 AgRP neurons) mice in basal state
(saline injection in the vena cava inferior) after
fasting for 16 hr.
Displayed values are means ± SEM. *p < 0.05;
**p < 0.01.These findings are consistent with reports that mice with tar-
geted disruption of leptin receptor signaling in the AgRP neurons
develop hyperphagia and obesity (van de Wall et al., 2008).
Moreover, AgRP neurons have been reported to be one of the
first hypothalamic neuronal populations to sense changes in
plasma metabolic signals and develop cellular leptin resistance
(Olofsson et al., 2013), possibly as a consequence of activating
inflammatory signaling cascades, i.e., JNK. Indeed, it has been
demonstrated that JNK activation can promote SOCS-3 expres-
sion, a well-characterized inhibitor of leptin action (Qin et al.,
2007; Bjørbaek et al., 1999; Howard et al., 2004). On the other
hand, JNK activation in AgRP neurons fails to promote cell-
autonomous and systemic insulin resistance, despite the fact
that JNK-dependent serine phosphorylation of IRS-1 has been
proposed to cause insulin resistance, at least in vitro (Aguirre
et al., 2002). However, mice with a mutation of IRS-1 serine
307 to alanine, which prevents this phosphorylation, are surpris-
ingly more insulin resistant under high-fat diet conditions than
their control littermates (Copps et al., 2010). These results indi-
cate that JNK activation does not necessarily result in attenua-Cell Reports 9, 1495–1506, Notion of insulin signaling via IRS-1 ser307
phosphorylation in vivo, consistent with
what we observe in AgRP neurons.
On the other hand, activation of IKK2 in
AgRP neurons causes cell-autonomous
and systemic insulin resistance in the
absence of leptin resistance and obesity.
In fact, this observation is consistent
with the notion that disruption of insulin
signaling in the AgRP neurons impairs
systemic insulin sensitivity through im-pairing insulin’s ability to suppress hepatic glucose production
but without affecting body weight regulation (Ko¨nner et al.,
2007). In contrast, previous studies had shown that ablation of
IKK2 from the CNS was sufficient to largely reduce the develop-
ment of obesity and leptin resistance upon high-fat diet feeding
(Zhang et al., 2008). This points to the possibility that IKK2 acts
in other neurons to promote weight gain and leptin resistance,
potentially through its action on hypothalamic neurogenesis (Li
et al., 2012).
In summary, our results indicate that both JNK1 and IKK2 in-
flammatory pathways are sufficient to impair aspects of energy
and glucose metabolism when activated in AgRP neurons,
clearly assigning a functional role of these signaling pathways
in this cell type to the manifestation of the metabolic syndrome.
EXPERIMENTAL PROCEDURES
Animal Care
All animal procedures were conducted in compliance with protocols approved
by local government authorities (Bezirksregierung Ko¨ln) and were in
accordance with NIH guidelines. Mice were housed in groups of 3–5 atvember 20, 2014 ª2014 The Authors 1503
22C–24C using a 12 hr light/12 hr dark cycle. Animals were fed normal chow
diet (Teklad Global Rodent 2018; Harlan) containing 53.5% carbohydrates,
18.5% protein, and 5.5% fat (12% of calories from fat) or high-fat diet (only
for the experiment of Figure 1A; HFD; C1057; Altromin) containing 32.7% car-
bohydrates, 20% protein, and 35.5% fat (55.2% of calories from fat). Animals
had ad libitum access to water at all times, and food was only withdrawn if
required for an experiment. Body weight was measured once a week.
Generation of Mice
Only male mice were used in these studies to avoid the effect of different
stages of estrous cycle on glucose homeostasis. NPYGFP, R26StopFLJNK1CA,
R26StopFLIKK2CA, Z/EG, LacZ, and AgRPCre mice have been described pre-
viously (Pal et al., 2013; Sasaki et al., 2006; Novak et al., 2000; Tong et al.,
2008). All mouse strains had been crossed onto a C57B6/N background for
at least three generations, and littermate controls were used at all times except
in reporter animal breedings for the AgRP. Instead, we crossed AgRPLacZ
transgenic mice with R26StopFL/FLIKK2CA.
Analytical Procedures
Bloodglucose valuesweredetermined fromwhole venousbloodusinganauto-
matic glucose monitor (Contour; Bayer). Serum hormones were measured as
recently described using commercially available ELISAs (Belgardt et al., 2010).
Indirect Calorimetry, Physical Activity, and Food Intake
All measurements were performed in a PhenoMaster System (TSE systems),
which allows measurement of metabolic performance and activity monitoring
by an infrared light-beam frame. Mice were placed at room temperature
(22C–24C) in 7.1 l chambers of the PhenoMaster open circuit calorimetry.
Mice were allowed to acclimatize in the chambers for at least 24 hr. Food
and water were provided ad libitum in the appropriate devices and measured
by the built-in automated instruments. Locomotor activity and parameters of
indirect calorimetry were measured for at least the following 48 hr. Presented
data are average values obtained in these recordings.
Body Composition
Nuclear magnetic resonance was employed to determine body composition
using the NMR Analyzer minispeq mq7.5 (Bruker Optik).
Perforated Patch Recordings
AgRP neurons were recorded at room temperature under current and voltage
clamp in the perforated patch configuration using an EPC10 patch-clamp
amplifier (HEKA). For detailed information, see the Supplemental Experimental
Procedures.
Data Analysis and Statistical Methods
Data analysis was performed with Igor Pro 6 (Wavemetrics) and Graphpad
Prism (version 5.0b; Graphpad Software). Numerical values are given as
mean ± SE. Box plots are generated according to Tukey; means are reflected
by ‘‘+’’ and medians by the dash, respectively. To determine differences in
means, t tests were performed. A significance level of 0.05 was accepted for
all tests. *p% 0.05; **p% 0.01; ***p% 0.001 versus controls.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2014.10.045.
ACKNOWLEDGMENTS
We are grateful to G. Schmall and T. Rayle for excellent secretarial assistance
and Jens Alber and Helmut Wratil for outstanding technical assistance. We
thank Joel Elmquist and Brad B. Lowell for the AgRPCremice used in this study.
We are grateful to Jiahuai Han and Anning Lin for plasmids containing MKK7D
and JNKK2-JNK1, respectively. We are grateful to Dr. A. F. Parlow and the
National Hormone and Peptide Program (NHPP) for the recombinant mouse1504 Cell Reports 9, 1495–1506, November 20, 2014 ª2014 The Autleptin. The images of the graphical abstract were adapted from Servier Med-
ical Art. M.S.-S. received support from the DFG through an Emmy Noether
Programme. E.T. received support from the IGSDHD. U.C. received support
from the Cologne Graduate School of Ageing Research. This work was sup-
ported by a grant from the DFG (BR 1492/7-1) to J.C.B. and was funded by
the DFG within the Excellence Initiative by German Federal and State Govern-
ments (CECAD), and the research leading to these results has received funding
from the European Community’s 7th Framework Programme (FP7/2007-2013)
under grant agreement no. 201608 (TOBI). This work was funded (in part) by
the Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases
(ICEMED) through the Initiative and Networking Fund of the Helmholtz
Association.
Received: April 7, 2014
Revised: July 10, 2014
Accepted: October 16, 2014
Published: November 13, 2014
REFERENCES
Aguirre, V., Werner, E.D., Giraud, J., Lee, Y.H., Shoelson, S.E., andWhite, M.F.
(2002). Phosphorylation of Ser307 in insulin receptor substrate-1 blocks inter-
actions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277,
1531–1537.
Ahn, S.M., and Choe, E.S. (2010). Alterations in GluR2 AMPA receptor phos-
phorylation at serine 880 following group I metabotropic glutamate receptor
stimulation in the rat dorsal striatum. J. Neurosci. Res. 88, 992–999.
Aponte, Y., Atasoy, D., and Sternson, S.M. (2011). AGRP neurons are sufficient
to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 14,
351–355.
Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.-W., Long, J.M.,
Wynshaw-Boris, A., Poli, G., Olefsky, J., and Karin, M. (2005). IKK-beta links
inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191–198.
Balthasar, N., Coppari, R., McMinn, J., Liu, S.M., Lee, C.E., Tang, V., Kenny,
C.D., McGovern, R.A., Chua, S.C., Jr., Elmquist, J.K., and Lowell, B.B.
(2004). Leptin receptor signaling in POMC neurons is required for normal
body weight homeostasis. Neuron 42, 983–991.
Bates, S.H., andMyers, M.G., Jr. (2003). The role of leptin receptor signaling in
feeding and neuroendocrine function. Trends Endocrinol. Metab. 14, 447–452.
Belgardt, B.F., and Bru¨ning, J.C. (2010). CNS leptin and insulin action in the
control of energy homeostasis. Ann. N Y Acad. Sci. 1212, 97–113.
Belgardt, B.F., Husch, A., Rother, E., Ernst, M.B., Wunderlich, F.T., Hampel,
B., Klo¨ckener, T., Alessi, D., Kloppenburg, P., and Bru¨ning, J.C. (2008).
PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and
-independent pathways in control of energy homeostasis and stress response.
Cell Metab. 7, 291–301.
Belgardt, B.F., Mauer, J., Wunderlich, F.T., Ernst, M.B., Pal, M., Spohn, G.,
Bro¨nneke, H.S., Brodesser, S., Hampel, B., Schauss, A.C., and Bru¨ning,
J.C. (2010). Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling
coordinately regulates glucose metabolism. Proc. Natl. Acad. Sci. USA 107,
6028–6033.
Bjørbaek, C., El-Haschimi, K., Frantz, J.D., and Flier, J.S. (1999). The role of
SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274, 30059–
30065.
Bockhart, V., Constantin, C.E., Ha¨ussler, A., Wijnvoord, N., Kanngiesser, M.,
Myrczek, T., Pickert, G., Popp, L., Sobotzik, J.-M., Pasparakis, M., et al.
(2009). Inhibitor kappaB Kinase beta deficiency in primary nociceptive neurons
increases TRP channel sensitivity. J. Neurosci. 29, 12919–12929.
Bogoyevitch, M.A. (2006). The isoform-specific functions of the c-Jun N-termi-
nal Kinases (JNKs): differences revealed by gene targeting. Bioessays 28,
923–934.
Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., and Shoe-
lson, S.E. (2005). Local and systemic insulin resistance resulting from hepatic
activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183–190.hors
Coll, A.P., Farooqi, I.S., and O’Rahilly, S. (2007). The hormonal control of food
intake. Cell 129, 251–262.
Copps, K.D., Hancer, N.J., Opare-Ado, L., Qiu, W., Walsh, C., and White,
M.F. (2010). Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab.
11, 84–92.
De Souza, C.T., Araujo, E.P., Bordin, S., Ashimine, R., Zollner, R.L., Boschero,
A.C., Saad, M.J.A., and Velloso, L.A. (2005). Consumption of a fat-rich diet ac-
tivates a proinflammatory response and induces insulin resistance in the hypo-
thalamus. Endocrinology 146, 4192–4199.
Enriori, P.J., Evans, A.E., Sinnayah, P., Jobst, E.E., Tonelli-Lemos, L., Billes,
S.K., Glavas, M.M., Grayson, B.E., Perello, M., Nillni, E.A., et al. (2007). Diet-
induced obesity causes severe but reversible leptin resistance in arcuate mel-
anocortin neurons. Cell Metab. 5, 181–194.
Gao, Y., Ottaway, N., Schriever, S.C., Legutko, B., Garcı´a-Ca´ceres, C., de la
Fuente, E., Mergen, C., Bour, S., Thaler, J.P., Seeley, R.J., et al. (2014). Hor-
mones and diet, but not body weight, control hypothalamic microglial activity.
Glia 62, 17–25.
Garcı´a-Ca´ceres, C., Yi, C.-X., and Tscho¨p, M.H. (2013). Hypothalamic astro-
cytes in obesity. Endocrinol. Metab. Clin. North Am. 42, 57–66.
Gosselin, D., and Rivest, S. (2008). MyD88 signaling in brain endothelial cells is
essential for the neuronal activity and glucocorticoid release during systemic
inflammation. Mol. Psychiatry 13, 480–497.
Gropp, E., Shanabrough, M., Borok, E., Xu, A.W., Janoschek, R., Buch, T.,
Plum, L., Balthasar, N., Hampel, B., Waisman, A., et al. (2005). Agouti-related
peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8,
1289–1291.
Hallschmid, M., Benedict, C., Schultes, B., Born, J., and Kern, W. (2008).
Obese men respond to cognitive but not to catabolic brain insulin signaling.
Int J Obes (Lond) 32, 275–282.
Hill, J.W., Elias, C.F., Fukuda, M., Williams, K.W., Berglund, E.D., Holland,
W.L., Cho, Y.-R., Chuang, J.-C., Xu, Y., Choi, M., et al. (2010). Direct insulin
and leptin action on pro-opiomelanocortin neurons is required for normal
glucose homeostasis and fertility. Cell Metab. 11, 286–297.
Hirosumi, J., Tuncman, G., Chang, L., Go¨rgu¨n, C.Z., Uysal, K.T., Maeda, K.,
Karin, M., and Hotamisligil, G.S. (2002). A central role for JNK in obesity and
insulin resistance. Nature 420, 333–336.
Holland, W.L., Brozinick, J.T., Wang, L.-P., Hawkins, E.D., Sargent, K.M., Liu,
Y., Narra, K., Hoehn, K.L., Knotts, T.A., Siesky, A., et al. (2007). Inhibition of
ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-
induced insulin resistance. Cell Metab. 5, 167–179.
Hotamisligil, G.S. (2008). Inflammation and endoplasmic reticulum stress in
obesity and diabetes. Int J Obes (Lond) 32 (Suppl 7), S52–S54.
Howard, J.K., Cave, B.J., Oksanen, L.J., Tzameli, I., Bjørbaek, C., and Flier,
J.S. (2004). Enhanced leptin sensitivity and attenuation of diet-induced obesity
in mice with haploinsufficiency of Socs3. Nat. Med. 10, 734–738.
Kitamura, T., Feng, Y., Kitamura, Y.I., Chua, S.C., Jr., Xu, A.W., Barsh, G.S.,
Rossetti, L., and Accili, D. (2006). Forkhead protein FoxO1 mediates Agrp-
dependent effects of leptin on food intake. Nat. Med. 12, 534–540.
Kleinridders, A., Schenten, D., Ko¨nner, A.C., Belgardt, B.F., Mauer, J., Oka-
mura, T., Wunderlich, F.T., Medzhitov, R., and Bru¨ning, J.C. (2009). MyD88
signaling in the CNS is required for development of fatty acid-induced leptin
resistance and diet-induced obesity. Cell Metab. 10, 249–259.
Ko¨nner, A.C., Janoschek, R., Plum, L., Jordan, S.D., Rother, E., Ma, X., Xu, C.,
Enriori, P., Hampel, B., Barsh, G.S., et al. (2007). Insulin action in AgRP-ex-
pressing neurons is required for suppression of hepatic glucose production.
Cell Metab. 5, 438–449.
Li, Q., and Verma, I.M. (2002). NF-kappaB regulation in the immune system.
Nat. Rev. Immunol. 2, 725–734.
Li, J., Tang, Y., and Cai, D. (2012). IKKb/NF-kB disrupts adult hypothalamic
neural stem cells to mediate a neurodegenerative mechanism of dietary
obesity and pre-diabetes. Nat. Cell Biol. 14, 999–1012.
Lin, H.V., Plum, L., Ono, H., Gutie´rrez-Jua´rez, R., Shanabrough, M., Borok, E.,
Horvath, T.L., Rossetti, L., and Accili, D. (2010). Divergent regulation of energyCell Reexpenditure and hepatic glucose production by insulin receptor in agouti-
related protein and POMC neurons. Diabetes 59, 337–346.
Luquet, S., Perez, F.A., Hnasko, T.S., and Palmiter, R.D. (2005). NPY/AgRP
neurons are essential for feeding in adult mice but can be ablated in neonates.
Science 310, 683–685.
Mu¨nzberg, H., Flier, J.S., and Bjørbaek, C. (2004). Region-specific leptin resis-
tance within the hypothalamus of diet-induced obese mice. Endocrinology
145, 4880–4889.
Novak, A., Guo, C., Yang, W., Nagy, A., and Lobe, C.G. (2000). Z/EG, a double
reporter mouse line that expresses enhanced green fluorescent protein upon
Cre-mediated excision. Genesis 28, 147–155.
Obici, S., Feng, Z., Karkanias, G., Baskin, D.G., and Rossetti, L. (2002a).
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin
resistance in rats. Nat. Neurosci. 5, 566–572.
Obici, S., Zhang, B.B., Karkanias, G., and Rossetti, L. (2002b). Hypothalamic
insulin signaling is required for inhibition of glucose production. Nat. Med. 8,
1376–1382.
Olofsson, L.E., Unger, E.K., Cheung, C.C., and Xu, A.W. (2013). Modulation of
AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypo-
thalamic leptin resistance. Proc. Natl. Acad. Sci. USA 110, E697–E706.
Ozcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N.N., Ozdelen, E.,
Tuncman, G., Go¨rgu¨n, C., Glimcher, L.H., and Hotamisligil, G.S. (2004). Endo-
plasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Sci-
ence 306, 457–461.
Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R.O.,
Go¨rgu¨n, C.Z., and Hotamisligil, G.S. (2006). Chemical chaperones reduce
ER stress and restore glucose homeostasis in a mouse model of type 2 dia-
betes. Science 313, 1137–1140.
Ozcan, L., Ergin, A.S., Lu, A., Chung, J., Sarkar, S., Nie, D., Myers, M.G., Jr.,
and Ozcan, U. (2009). Endoplasmic reticulum stress plays a central role in
development of leptin resistance. Cell Metab. 9, 35–51.
Pal, M., Wunderlich, C.M., Spohn, G., Bro¨nneke, H.S., Schmidt-Supprian, M.,
and Wunderlich, F.T. (2013). Alteration of JNK-1 signaling in skeletal muscle
fails to affect glucose homeostasis and obesity-associated insulin resistance
in mice. PLoS ONE 8, e54247.
Plum, L., Belgardt, B.F., and Bru¨ning, J.C. (2006a). Central insulin action in en-
ergy and glucose homeostasis. J. Clin. Invest. 116, 1761–1766.
Plum, L., Ma, X., Hampel, B., Balthasar, N., Coppari, R., Mu¨nzberg, H., Sha-
nabrough, M., Burdakov, D., Rother, E., Janoschek, R., et al. (2006b).
Enhanced PIP3 signaling in POMC neurons causes KATP channel activation
and leads to diet-sensitive obesity. J. Clin. Invest. 116, 1886–1901.
Purkayastha, S., and Cai, D. (2013). Disruption of neurogenesis by hypotha-
lamic inflammation in obesity or aging. Rev. Endocr. Metab. Disord. 14,
351–356.
Qin, H., Roberts, K.L., Niyongere, S.A., Cong, Y., Elson, C.O., and Benveniste,
E.N. (2007). Molecular mechanism of lipopolysaccharide-induced SOCS-3
gene expression in macrophages and microglia. J. Immunol. 179, 5966–5976.
Ring, L.E., and Zeltser, L.M. (2010). Disruption of hypothalamic leptin signaling
in mice leads to early-onset obesity, but physiological adaptations in mature
animals stabilize adiposity levels. J. Clin. Invest. 120, 2931–2941.
Sabio, G., Kennedy, N.J., Cavanagh-Kyros, J., Jung, D.Y., Ko, H.J., Ong, H.,
Barrett, T., Kim, J.K., and Davis, R.J. (2010). Role of muscle c-Jun NH2-termi-
nal kinase 1 in obesity-induced insulin resistance. Mol. Cell. Biol. 30, 106–115.
Sasaki, Y., Derudder, E., Hobeika, E., Pelanda, R., Reth, M., Rajewsky, K., and
Schmidt-Supprian, M. (2006). Canonical NF-kappaB activity, dispensable for
B cell development, replaces BAFF-receptor signals and promotes B cell pro-
liferation upon activation. Immunity 24, 729–739.
Schmeisser, M.J., Baumann, B., Johannsen, S., Vindedal, G.F., Jensen, V.,
Hvalby, Ø.C., Sprengel, R., Seither, J., Maqbool, A., Magnutzki, A., et al.
(2012). IkB kinase/nuclear factor kB-dependent insulin-like growth factor 2
(Igf2) expression regulates synapse formation and spine maturation via Igf2 re-
ceptor signaling. J. Neurosci. 32, 5688–5703.ports 9, 1495–1506, November 20, 2014 ª2014 The Authors 1505
Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., and Flier, J.S. (2006).
TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin.
Invest. 116, 3015–3025.
Thaler, J.P., Yi, C.-X., Schur, E.A., Guyenet, S.J., Hwang, B.H., Dietrich, M.O.,
Zhao, X., Sarruf, D.A., Izgur, V., Maravilla, K.R., et al. (2012). Obesity is asso-
ciated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122,
153–162.
Thomas, G.M., Lin, D.-T., Nuriya, M., and Huganir, R.L. (2008). Rapid and bi-
directional regulation of AMPA receptor phosphorylation and trafficking by
JNK. EMBO J. 27, 361–372.
Tong, Q., Ye, C.-P., Jones, J.E., Elmquist, J.K., and Lowell, B.B. (2008). Syn-
aptic release of GABA by AgRP neurons is required for normal regulation of en-
ergy balance. Nat. Neurosci. 11, 998–1000.
Unger, E.K., Piper, M.L., Olofsson, L.E., and Xu, A.W. (2010). Functional role of
c-Jun-N-terminal kinase in feeding regulation. Endocrinology 151, 671–682.
van de Wall, E., Leshan, R., Xu, A.W., Balthasar, N., Coppari, R., Liu, S.M., Jo,
Y.H., MacKenzie, R.G., Allison, D.B., Dun, N.J., et al. (2008). Collective and in-
dividual functions of leptin receptor modulated neurons controlling meta-
bolism and ingestion. Endocrinology 149, 1773–1785.
Vogt, M.C., and Bru¨ning, J.C. (2013). CNS insulin signaling in the control of en-
ergy homeostasis and glucose metabolism - from embryo to old age. Trends
Endocrinol. Metab. 24, 76–84.1506 Cell Reports 9, 1495–1506, November 20, 2014 ª2014 The AutWang, Y., Su, B., Sah, V.P., Brown, J.H., Han, J., and Chien, K.R. (1998). Car-
diac hypertrophy induced bymitogen-activated protein kinase kinase 7, a spe-
cific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J. Biol.
Chem. 273, 5423–5426.
Williams, K.W., Margatho, L.O., Lee, C.E., Choi, M., Lee, S., Scott, M.M., Elias,
C.F., and Elmquist, J.K. (2010). Segregation of acute leptin and insulin effects
in distinct populations of arcuate proopiomelanocortin neurons. J. Neurosci.
30, 2472–2479.
Xu, A.W., Ste-Marie, L., Kaelin, C.B., and Barsh, G.S. (2007). Inactivation of
signal transducer and activator of transcription 3 in proopiomelanocortin
(Pomc) neurons causes decreased pomc expression, mild obesity, and de-
fects in compensatory refeeding. Endocrinology 148, 72–80.
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M., and
Shoelson, S.E. (2001). Reversal of obesity- and diet-induced insulin resistance
with salicylates or targeted disruption of Ikkbeta. Science 293, 1673–1677.
Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H., and Cai, D. (2008). Hypo-
thalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbal-
ance and obesity. Cell 135, 61–73.
Zheng, C., Xiang, J., Hunter, T., and Lin, A. (1999). The JNKK2-JNK1 fusion
protein acts as a constitutively active c-Jun kinase that stimulates c-Jun tran-
scription activity. J. Biol. Chem. 274, 28966–28971.hors
